Home Intervjuer How Magle Group focus their use of DSM

How Magle Group focus their use of DSM

Magle Group

How Magle Group focus their use of DSM

21 augusti, 2024

The company aims to establish itself as a leader in life-changing healthcare innovations. Watch Justin Pierce, CEO and Helena Ossmer Thedius, Chief Marketing and Innovation Officer, explain their technology platform of degradable starch microspheres (DSM), serving as the base for development of new products, in BioStock Studio.

YouTube video

Innehållet i BioStocks nyheter och analyser är oberoende men BioStocks verksamhet är i viss mån finansierad av bolag i branschen. Detta inlägg avser ett bolag som BioStock erhållit finansiering från.

Prenumerera på BioStocks nyhetsbrev